Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Each study has a usefulness score out of 100 (rubric version 4.0). Tap a score to see what makes it up.

Highest usefulness score first. Studies without a score come last.

  1. Effect of Cognitive Training in Fully Immersive Virtual Reality on Visuospatial Function and Frontal-Occipital Functional Connectivity in Predementia: Randomized Controlled Trial

    ✓ Peer-reviewed alzhub usefulness score 71 out of 100. Journal of medical Internet research 2021-05-06 Prevention trials

    However, the results of recent studies using semi-immersive virtual reality (VR)-assisted cognitive training are inconsistent.

  2. Usability and User Experience of Cognitive Intervention Technologies for Elderly People With MCI or Dementia: A Systematic Review

    ✓ Peer-reviewed alzhub usefulness score 71 out of 100. Frontiers in psychology 2021-04-22 Prevention trials

    Measuring usability and UX in cognitive intervention technologies for older adults with MCI or dementia provides an integrated view that can contribute to their development according to the needs and characteristics of the target population.

  3. Association of sleep duration in middle and old age with incidence of dementia

    ✓ Peer-reviewed alzhub usefulness score 71 out of 100. Nature communications 2021-04-20 How common it is

    Sleep dysregulation is a feature of dementia but it remains unclear whether sleep duration prior to old age is associated with dementia incidence.

    Why it matters

    In 7,959 Whitehall II participants followed for 25 years (521 dementia diagnoses), sleeping six hours or less at age 50 or 60 was linked to a higher dementia risk than sleeping 7 hours (hazard ratios 1.22 and 1.37), while the estimate at age 70 was "imprecisely estimated" (1.24, 0.98–1.57). People who slept six hours or less at all three ages had about a 30% higher risk than persistent 7-hour sleepers, even after accounting for "sociodemographic, behavioural, cardiometabolic, and mental health factors". This is an association: it does not show that short sleep causes dementia or that sleeping longer would prevent it.

  4. Α Virtual Reality App for Physical and Cognitive Training of Older People With Mild Cognitive Impairment: Mixed Methods Feasibility Study

    ✓ Peer-reviewed alzhub usefulness score 71 out of 100. JMIR serious games 2021-03-24 Prevention trials

    However, to replace existing nonpharmaceutical treatment training protocols, VR platforms need significant improvement if they are to appeal to older people with symptoms of cognitive decline and meet their specific needs.

  5. Using a distribution-based approach and systematic review methods to derive minimum clinically important differences

    ✓ Peer-reviewed alzhub usefulness score 71 out of 100. BMC medical research methodology 2021-02-26 Treatments

    A distribution-based approach using data included in a systematic review approximated known MCIDs.

    Why it matters

    This methods paper used data from trials of cognitive-enhancing medications for dementia to estimate the smallest meaningful change on cognitive scales. It does not test a treatment or report new results about preventing or curing Alzheimer disease.

  6. Non-genetic risk and protective factors and biomarkers for neurological disorders: a meta-umbrella systematic review of umbrella reviews

    ✓ Peer-reviewed alzhub usefulness score 71 out of 100. BMC medicine 2021-01-13 Prevention trials

    The search yielded 115 distinctly named non-genetic risk and protective factors with a significant association, with various strengths of evidence.

  7. Key Intervention Categories to Provide Person-Centered Dementia Care: A Systematic Review of Person-Centered Interventions

    ✓ Peer-reviewed alzhub usefulness score 71 out of 100. Journal of Alzheimer's disease : JAD 2021-01-01 Prevention trials

    Our findings provide a current overview of published PC-interventions in dementia, which followed heterogeneous approaches under the PCC-concept.

  8. The Japan-Multimodal Intervention Trial for Prevention of Dementia (J-MINT): The Study Protocol for an 18-Month, Multicenter, Randomized, Controlled Trial

    ✓ Peer-reviewed alzhub usefulness score 71 out of 100. The journal of prevention of Alzheimer's disease 2021-01-01 Prevention trials

    This trial that enlist the support of private enterprises will lead to the creation of new services for dementia prevention as well as to verify the effectiveness of multi-domain interventions for dementia prevention.

  9. Pharmacological and non-pharmacological interventions to enhance sleep in mild cognitive impairment and mild Alzheimer's disease: A systematic review

    ✓ Peer-reviewed alzhub usefulness score 71 out of 100. Journal of sleep research 2020-12-02 Mild cognitive impairment

    Suboptimal sleep causes cognitive decline and probably accelerates Alzheimer's Disease (AD) progression.

    Why it matters

    This systematic review of 16 studies with 1,056 participants found that adapted cognitive behavioural therapy for insomnia and a structured limbs exercise programme each significantly improved sleep quality, and that suvorexant and melatonin improved certain sleep measures in small studies. The review addresses sleep interventions in mild cognitive impairment and mild dementia, but does not show that improving sleep prevents or slows Alzheimer's disease.

  10. Enhancing shared and surrogate decision making for people living with dementia: A systematic review of the effectiveness of interventions

    ✓ Peer-reviewed alzhub usefulness score 71 out of 100. Health expectations : an international journal of public participation in health care and health policy 2020-11-28 End-of-life care

    Decision-making interventions typically consist of multiple components which aim to establish preferences for future health care.

  11. Antibiotic use during end-of-life care: A systematic literature review and meta-analysis

    ✓ Peer-reviewed alzhub usefulness score 71 out of 100. Infection control and hospital epidemiology 2020-11-11 End-of-life care

    Future studies are needed to evaluate the benefits and harms of using antibiotics for patients during EOL care in diverse patient populations.

  12. Cerebrovascular risk factors impact frontoparietal network integrity and executive function in healthy ageing

    ✓ Peer-reviewed alzhub usefulness score 71 out of 100. Nature communications 2020-09-07 Long-term cohort studies

    Healthy cognitive ageing is a societal and public health priority.

    Why it matters

    In 22,059 healthy UK Biobank participants, people with more cerebrovascular risk factors had worse cognitive abilities. Statistical modelling linked that risk to reduced grey matter and white matter integrity in a fronto-parietal brain network that supports executive function (planning, switching and controlling attention). This is an observational association in people without dementia. It does not show that lowering vascular risk prevents Alzheimer's disease.

  13. Dietary Factors and Neurodegenerative Disorders: An Umbrella Review of Meta-Analyses of Prospective Studies

    ✓ Peer-reviewed alzhub usefulness score 71 out of 100. Advances in nutrition (Bethesda, Md.) 2020-09-01 Prevention trials

    Diet has been hypothesized to be associated with neurodegenerative disorders.

  14. Cognitive training interventions for dementia and mild cognitive impairment in Parkinson's disease

    ✓ Peer-reviewed alzhub usefulness score 71 out of 100. The Cochrane database of systematic reviews 2020-02-26 Disparities

    Selection criteria We included randomised controlled trials where the participants had PDD or PD-MCI, and where the intervention was intended to train general or specific areas of cognitive function, targeting either a single domain or multiple domains of cognition, and was compared to a control condition.

    Why it matters

    This review of seven trials with 225 participants found no clear evidence that cognitive training improved global cognition in people with Parkinson's disease dementia or mild cognitive impairment. The evidence was low certainty because of risk of bias, imprecision and the small number of studies and participants.

  15. Foreign language learning in older age does not improve memory or intelligence: Evidence from a randomized controlled study

    ✓ Peer-reviewed alzhub usefulness score 71 out of 100. Psychology and aging 2020-02-03 Prevention trials

    Foreign language learning in older age has been proposed as a promising avenue for combatting age-related cognitive decline.

  16. Improving shared decision-making in advance care planning: Implementation of a cluster randomized staff intervention in dementia care

    ✓ Peer-reviewed alzhub usefulness score 71 out of 100. Patient education and counseling 2019-11-26 End-of-life care

    Nursing home staff benefits from this training in shared decision-making.

  17. New evidence on the management of Lewy body dementia

    ✓ Peer-reviewed alzhub usefulness score 71 out of 100. The Lancet. Neurology 2019-09-10 Risk factors

    Dementia with Lewy bodies and Parkinson's disease dementia, jointly known as Lewy body dementia, are common neurodegenerative conditions.

    Why it matters

    This review states that clinical trials and meta-analyses now provide an evidence base for treating cognitive, neuropsychiatric, and motor symptoms in Lewy body dementia, but that treatments can improve one symptom while worsening another and evidence gaps remain. It is about managing symptoms of Lewy body dementia, not curing or preventing Alzheimer's disease.

  18. High and increasing blood pressure from early adulthood into midlife seems to be associated with increased WMHV and smaller brain volumes at 69-71 years of age.

    Why it matters

    In this long-term cohort, higher blood pressure and greater increases in blood pressure from early adulthood into midlife were linked to more white matter damage and smaller brain volumes in late life. This suggests that managing blood pressure across adulthood may help protect brain structure, but the study did not test whether treating blood pressure prevents Alzheimer's disease.

  19. Association of social contact with dementia and cognition: 28-year follow-up of the Whitehall II cohort study

    ✓ Peer-reviewed alzhub usefulness score 71 out of 100. PLoS Medicine 2019-08-02 Prevention and risk

    More frequent social contact at age 60 years was associated with lower dementia risk (hazard ratio [HR] for each SD higher social contact frequency = 0.88 [95% CI 0.79, 0.98], p = 0.02); effect size of the association of social contact at 50 or 70 years with dementia was similar (0.92 [95% CI 0.83, 1.02], p = 0.13 and 0.91 [95% CI 0.78, 1.06], p = 0.23, respectively) but not statistically significant.

    Why it matters

    This 28-year follow-up of the Whitehall II cohort found that more frequent social contact at age 60 was associated with lower dementia risk, and more frequent social contact during midlife was associated with better subsequent cognitive trajectory. It suggests social contact may be linked to lower dementia risk, but the associations at ages 50 and 70 were not statistically significant, and it does not show a treatment or cure.

  20. Can Persons with Dementia Meaningfully Participate in Advance Care Planning Discussions? A Mixed-Methods Study of SPIRIT

    ✓ Peer-reviewed alzhub usefulness score 71 out of 100. Journal of palliative medicine 2019-08-02 End-of-life care

    All 23 were able to articulate their end-of-life wishes very or somewhat coherently during the SPIRIT session; of those, 14 PWDs had moderate dementia.

  21. Sex-Specific Differences in End-of-Life Burdensome Interventions and Antibiotic Therapy in Nursing Home Residents With Advanced Dementia

    ✓ Peer-reviewed alzhub usefulness score 71 out of 100. JAMA network open 2019-08-02 End-of-life care

    The final cohort included 27 243 nursing home residents with advanced dementia (19 363 [71.1%] women) who died between June 1, 2010, and March 31, 2015, at the median (interquartile range) age of 88 (83-92) years.

  22. Association of Midlife to Late-Life Blood Pressure Patterns With Incident Dementia

    ✓ Peer-reviewed alzhub usefulness score 71 out of 100. JAMA 2019-08-01 Disparities

    Late-life declines in blood pressure following prolonged hypertension may be associated with poor cognitive outcomes.

    Why it matters

    In this long-term cohort, people with sustained midlife-to-late-life hypertension, or with midlife hypertension and late-life hypotension, had higher risk of later dementia. It identifies blood pressure patterns as risk factors but does not test whether treating blood pressure prevents dementia.

  23. The impact of APOE genotype on survival: Results of 38,537 participants from six population-based cohorts (E2-CHARGE)

    ✓ Peer-reviewed alzhub usefulness score 71 out of 100. PloS one 2019-07-29 Long-term cohort studies

    The APOE-ε4 allele has long been associated with increased risks of Alzheimer's disease and mortality, but the effect of the less prevalent APOE-ε2 allele on diseases in the elderly and survival remains elusive.

    Why it matters

    This study combined data from 38,537 people across six population-based cohorts to examine how APOE genotypes, particularly the less common APOE-ε2 allele, relate to survival. The APOE-ε4 allele was already known to increase risks of Alzheimer's disease and mortality, but the effect of APOE-ε2 on diseases in the elderly and survival was less clear.

  24. Development and Validation of a Deep Learning Algorithm for Mortality Prediction in Selecting Patients With Dementia for Earlier Palliative Care Interventions

    ✓ Peer-reviewed alzhub usefulness score 71 out of 100. JAMA network open 2019-07-03 Clinical safety

    A deep learning algorithm based on patient demographic information and longitudinal clinical notes appeared to show promising results in predicting mortality among patients with dementia in different time frames.

  25. Computerised cognitive training for preventing dementia in people with mild cognitive impairment

    ✓ Peer-reviewed alzhub usefulness score 71 out of 100. The Cochrane database of systematic reviews 2019-03-13 Mild cognitive impairment

    Selection criteria We included randomised controlled trials (RCTs) and quasi-RCTs in which cognitive training via interactive computerised technology was compared with an active or inactive control intervention.

    Why it matters

    This review of eight randomized trials with 660 participants found very low-quality evidence, and no trial reported data on incident dementia, so no conclusions could be drawn about whether computerized cognitive training prevents dementia. There was low-quality evidence suggesting probably no effect on speed of processing, verbal fluency or quality of life, so this review does not support computerized cognitive training as a way to prevent dementia.

From across this topic

10 of the 7,967 studies in this topic, picked by a fixed rule (a hash of each study's address), not by score or date; each page of this list shows a different 10. The same 10 appear here every time.

Other topics